**PURPOSE:** We recently described a bioinspired material composed of nanoparticulate mineralized collagen glycosaminoglycan (MC-GAG) that induces efficient osteogenic differentiation of human mesenchymal stem cells (hMSCs) without the addition of exogenous growth factors, thereby suggestive of a promising, growth factor-free, materials-based method for clinically utilizable bone regeneration. We have previously reported that MC-GAG scaffolds autogenously induce BMP receptor signaling via the canonical (Smad1/5) pathway. However, the necessary and sufficient components of this mechanism remain unknown. Our current study evaluates the contribution of the non-canonical (MAP kinase) pathway in MC-GAG induced osteogenesis.

**METHODS:** hMSCs were cultured in osteogenic media on non-mineralized (Col-GAG) and nanoparticulate mineralized (MC-GAG) collagen glycosaminoglycan scaffolds. Scaffolds were untreated or treated with the MAP kinase inhibitor PD98059 at 20 μM and 50 μM for 4 days, 14 days, 24 days, 4 weeks, and 8 weeks. Gene and protein expression were measured using quantitative RT-PCR and western blot analysis. Scaffolds were subjected to histochemical and micro-computed tomographic analyses.

**RESULTS:** Inhibition of the non-canonical BMP receptor signaling pathway resulted in a decrease in expression of early osteogenic genes. Western blot analysis demonstrated that PD98059 inhibited phosphorylation of ERK1/2 and JNK without affecting Smad1/5, p38, and Akt phosphorylation. At 4 and 8 weeks of culture, Runx2 protein expression and mineralization on μCT scans were decreased in the presence of PD98059.

**CONCLUSION:** Activation of the non-canonical BMP receptor signaling pathway is essential for osteogenic differentiation of hMSCs on MC-GAG scaffolds.
